Ligand Pharmaceuticals (LGND)

Add to Watchlists Create an Alert
27.38 -0.36  -1.30%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Ligand Pharmaceuticals Return on Equity:

-2.87% for Dec. 31, 2012
View Full Chart

Ligand Pharmaceuticals Return on Equity Chart

    Ligand Pharmaceuticals Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -2.87%
    Sept. 30, 2012 22.83%
    June 30, 2012 -8.56%
    March 31, 2012 15.46%
    Dec. 31, 2011 302.7%
    Sept. 30, 2011
    June 30, 2011
    March 31, 2011
    Dec. 31, 2010
    Sept. 30, 2010
    June 30, 2010
    March 31, 2010
    Dec. 31, 2009
    Sept. 30, 2009
    June 30, 2009
    March 31, 2009 -2428%
    Dec. 31, 2008 -763.4%
    Sept. 30, 2008 -111.7%
    June 30, 2008 -11.92%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    LGND Return on Equity Benchmarks

    Companies
    Medicines 9.44%
    GlaxoSmithKline 60.64%
    Momenta Pharmaceuticals -20.76%

    LGND Return on Equity Rankings

    Overall 57th percentile
    3425 of 8005
    Sector 63rd percentile
    248 of 686 in Healthcare
    Industry 60th percentile
    27 of 68 in Drug Manufacturers - Specialty & Generic

    LGND Return on Equity Range, Past 5 Years

    Minimum -2428% Mar 2009
    Maximum 302.7% Dec 2011
    Average -331.7%